IP Library › Granted Patent US 8,380,306
Granted Patent B2
US 8,380,306 · App. 13/193,866 · Granted Feb 19, 2013

Implantable electrode

Inventor: Christopher John Pickett (Norfolk, GB)
Assignee: Biotectix, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,380,306
App. No.
13/193,866
Granted
Feb 19, 2013
Kind
B2
Abstract

An implantable electrode, for an implantable tissue stimulator, has an electrically conductive porous material comprising metal carbide, metal nitride, metal carbonitride, metal oxide or metal oxynitride and one or more coating layers on a surface thereof. The coating layer or at least one of the coating layers, is for contact with body tissue when the electrode is implanted. Each coating layer is an electrically conductive layer of polymer having a polypyrrole polymeric backbone or polythiophene polymeric backbone. The coating layer or layers are formed in situ by electropolymerisation. The polypyrrole or polythiophene may be substituted. The coating layer or layers can provide high charge storage capacitance and a fast discharging profile, as well as biocompatibility.

Claims (47)

1. An implantable electrode having an electrically conductive porous material comprising metal carbide, metal nitride, metal carbonitride, metal oxide or metal oxynitride and one or more coating layers on a surface of said material, said coating layer or at least one of said coating layers being for contact with body tissue when the electrode is implanted, and each said coating layer being an electrically conductive layer of polymer having a polypyrrole polymeric backbone or polythiophene polypyrrole substituted at the 1-position (N-atom) or the 3-position with a substituent —A-X or an allyl-terminated pendent group, or is a polythiophene substituted at the 3-position with a substituent —X, —A-X, or an allyl-terminated pendent group, wherein:

A is alkylene or alkenylene of 1-6 carbon atoms;

X is —COOH, —COO - , —COOR′, —CONH 2 , —CONHR′, —CON(R′) 2 , —COR′, —F, —Cl, —Br, —I, —CN, —NO 2 , —OH, —OR′, —SH, —SR′, —O-CO-R′, —NH 2 , —NHR′, —NH(R′) 2 , —N(R′) 3 + , —NH-CO-R′, —NH-CO-H, —NR′-CO-R′, —NR′-SO 2 H, —NR′-SO 2 R′, —SO 2 R′, —OSO 2 R′ or —OPO;

R′ is alkyl or alkenyl of 1-6 carbon atoms; and

the allyl-terminated pendent group comprises —O-CH 2 -CH=CH 2 , —S-CH 2 - CH=CH 2 , —S(=O)-CH 2 -CH=CH 2 , —Se-CH 2 -CH=CH 2 , or —Se(=O)-CH 2 -CH=CH 2 .

2. An implantable electrode according to claim 1 , wherein the at least one said coating layer is a polypyrrole derivative in the form of polypyrrole substituted at the 1-position (N-atom) and the 3-position.

3. An implantable electrode according to claim 1 , wherein the electrically conductive porous material comprises metal carbide, metal nitride or metal carbonitride.

4. An implantable electrode according to claim 3 , wherein the metal carbide, metal nitride or metal carbonitride is TiC, TiN, ZrC, ZrN, TaC, TaN or Ti(C,N).

5. An implantable tissue stimulator having an electrode according to claim 3 .

6. An implantable tissue stimulator according to claim 5 , having electrical power supply means and means for applying electrical stimulation pulses to the electrode using electrical power from the power supply means.

7. An implantable tissue stimulator according to claim 5 , which is a pacemaker, a defibrillator, a bone stimulator or a neuro-stimulator.

8. An implantable electrode according to claim 1 , wherein the porous material is supported on a metallic base body, and the coating layer has a thickness in the range from a molecular monolayer to 10 μm.

9. An implantable electrode according to claim 8 , wherein the coating layer has a thickness in the range from 0.01 μm to 1 μm.

10. An implantable electrode according to claim 1 , having at least two said coating layers which have respectively different substituted pyrrole monomeric units or different substituted thiophene monomeric units.

11. An implantable electrode according to claim 1 , wherein the or each said coating layer is free of non-exchangeable or non-mobile anions extraneous to said polymer.

12. An implantable tissue stimulator having an electrode according to claim 1 .

13. An implantable tissue stimulator according to claim 12 , having electrical power supply means and means for applying electrical stimulation pulses to the electrode using electrical power from the power supply means.

14. An implantable tissue stimulator according to claim 12 , which is a pacemaker, a defibrillator, a bone stimulator or a neuro-stimulator.

15. A method of making an implantable electrode acording to claim 1 , the method including the step of electropolymerizing pyrrole, a substituted pyrrole, thiophene or a substituted thiophene in situ on the electrically conductive porous material to form the coating layer as an electropolymerized polymer.

16. A method according to claim 15 , including the step of reacting the electropolymerized polymer after polymerization to add a substituent or change the substituent.

17. A method according to claim 15 , wherein the electrically conductive porous material comprises metal carbide, metal nitride or metal carbonitride.

18. An implantable electrode according to claim 1 , wherein the substituent is —A-X and A is alkylene or alkenylene having 1-3 carbon atoms.

19. An implantable electrode according to claim 1 , wherein the substituent is —A-X and A is unbranched alkylene or unbranched alkenylene.

20. An implantable electrode according to claim 1 , wherein the substituent is —A-X and A is unsubstituted.

21. An implantable electrode according to claim 1 , wherein the substituent is —A-X and A is substituted.

22. An implantable electrode according to claim 1 , wherein the substituent is —A-X and A is substituted with —COOH, —COO - , —COOR′, —CONH 2 , —CONHR′, —CON(R′) 2 , —COR′, —F, —Cl, —Br, —I, —CN, —NO 2 , —OH, —OR′, —SH, —SR′, —O-CO-R′, —NH 2 , —NHR′, —NH(R′) 2 , —N(R′) 3 + , —NH-CO-R′, —NH-CO-H, —NR′-CO-R′, —NR′-SO 2 H, —NR′-SO 2 R′, —SO 2 R′, —OSO 2 R′, or OPO 3 wherein R′ is alkyl or alkenyl of 1-6 carbon atoms.

23. An implantable electrode according to claim 1 , wherein R′ of the substituent group is from 1-4 carbon atoms.

24. An implantable electrode according to claim 1 , wherein X of the substituent group at the 3 position of pyrrole or thiophene is —COOH, —COO - , —COOR , —Cl, —SH, or —OPO 3 .

25. An implantable electrode according to claim 1 , wherein X of the substituent group at the 3 position of pyrrole or thiophene is —COOH or —COO - or —SH.

26. An implantable electrode according to claim 1 , wherein X of the substitutent group at the 3 position of pyrrole or thiophene is —COOH or —COO - .

27. An implantable electrode according to claim 1 , wherein the polypyrrole or the polythiophene has an allyl-terminated pendent group comprising —C(=O)-O-CH 2 -CH=CH 2 , —S-S-CH 2 -CH=CH 2 , —S(=O)-S-CH 2 -CH=CH 2 , —CH 2 -S(=O)-CH 2 -CH=CH 2 , or —S-S(=O)-CH 2 -CH=CH 2 .

28. An implantable electrode according to claim 1 , wherein the polypyrrole or the polythiopene has an allyl-terminated pendent group bound to a pyrrole or a thiophene ring via an amido, ester or ether moiety.

29. An implantable electrode according to claim 1 , wherein the polypyrrole or the polythiophene has an allyl-terminated pendent group and is derived from a monomer A*-B-C-D-E wherein:

A* is a pyrrole ring or a thiophene ring;

B is absent or C 1 -C 20 alkylene;

C is —CO-NH—, —CO-O—or —O—;

D is absent or C 1 -C 20 alkylene; and

E is the allyl-terminated pendent group.

30. An implantable electrode according to claim 29 , wherein B or D is absent.

31. An implantable electrode according to claim 29 , wherein B and D are absent.

32. An implantable electrode according to claim 29 , wherein B or D is C 1 -C 20 alkylene.

33. An implantable electrode according to claim 29 , wherein B and D are C 1 -C 20 alkylene.

34. An implantable electrode according to claim 29 , wherein B or D are branched C 1 -C 20 alkylene.

35. An implantable electrode according to claim 29 , wherein B or D are unbranched C 1 -C 20 alkylene.

36. An implantable electrode according to claim 29 , wherein C is —CO-NH—.

37. An implantable electrode according to claim 29 , wherein B or D is C 1 -C 20 alkylene substituted with —COOH, —COO - , —COOR′, —CONH 2 , —CONHR′, —CON(R′) 2 , —COR′, —F, —Cl, —Br, —I, —CN, —NO 2 , —OH, —OR′, —SH, —SR′, —O-CO-R′, —NH 2 , —NHR′, —NH(R′) 2 , —N(R′) 3 + , —NH-CO-R′, —NH-CO-H, —NR′-CO-R′, —NR′-SO 2 H, —NR′-SO 2 R′, —SO 2 R′, —OSO 2 R′, —OPO 3 , —C 5 —C 20 aryl, —C 1 C 7 alkyl-C 5 -C 20 aryl, or —C 1 —C 7 alkenyl-C 5 —C 20 aryl wherein R′ is alkyl or alkenyl of 1-6 carbon atoms .

38. An implantable electrode according to claim 1 , wherein the substituent is —X.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2018
From: BIOTECTIX, LLC
To: HERAEUS MEDICAL COMPONENTS LLC
Reel/Frame 044819/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2011
From: PICKETT, CHRISTOPHER JOHN
To: BIOTECTIX, LLC
Reel/Frame 026937/0739 →
Priority Claims (1)
GB 1012808.0 · Jul 29, 2010 · national
Continuity (1)
Related Publication 20120029585A1 · Feb 2, 2012